Trial of Argon Plasma Coagulation Versus APC and APC and Hemospray in the Treatment of Radiation Proctitis

British Columbia Cancer Agency

Status: Unknown

Conditions: Rectal Bleeding

Treatments: Other: Hemospray

Study type: Interventional

Funder types: Other

Identifiers

NCT02233933

RadP

Details and patient eligibility

About

Randomized trial of Argon Plasma Coagulation compared with Argon Plasma Coagulation and Hemospray in the therapy of bleeding from Radiation Proctitis

Full description

20 patients with Radiation Proctitis will be randomized to receive either Argon Plasma Coagulation therapy alone or therapy with APC followed by Hemospray administration ;the treatment in each arm is administered during a sigmoidoscopic examination

Enrollment: 20 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• bleeding from radiation proctitis

Exclusion criteria

• pregnancy bleeding diathesis

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Factorial Assignment

Masking: None (Open label)

---

20 participants in 2 patient groups

argon plasma coagulation

Active Comparator group

Description:

argon plasma coagulation of radiation proctitis

Treatment:

Other: Hemospray

argon plasma coagulator and hemospray

Experimental group

Description:

treatment of radiation proctitis with argon plasma coagulator followed by application of hemospray

Treatment:

Other: Hemospray